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In November 2011, a 31-year-old female patient was referred to the Cardiology Division for uncontrolled hypertension. 
She had been hospitalized for a urinary tract infection. Her sys-
tolic blood pressure was >200 mm Hg. She was obese. Her body 
mass index was 29 kg/m2, which is higher than the average body 
mass index among Korean women. She had a history of ulcer-
ative colitis currently under remission, and she had a history 
of preeclampsia 3 and 5 years previously. She had 2 children. 
She had type 2 diabetes mellitus and was taking regular oral 
medication. She also had recurrent urinary tract infections. She 
complained of headache, nausea, vomiting, and blurred vision.
Blood and urine tests were performed. Except for abnormal 
fasting glucose and hemoglobin A1C, most tests were within 
the normal range. Her thyroid function was normal, and her 
albumin:creatinine ratio in the urinary analysis was slightly 
above the reference range at 41.34. Her electrocardiagram 
(ECG) showed no evidence of left ventricular hypertrophy or 
any other abnormalities. Her left ventricular systolic function 
was normal and left ventricular mass index at 61.8 g/m2 was 
within the normal range. We consulted the Ophthalmology 
Division as she complained of blurred vision. Ophthalmological 
examination revealed no retinal abnormalities.
We proceeded to follow the algorithm for resistant hyper-
tension (Figure 1).1 The first step is to exclude white coat 
hypertension; second, to identify and reverse contributing fac-
tors; and third, to discontinue and minimize potential inter-
fering factors and perform screening for secondary causes of 
hypertension.
Ambulatory blood pressure monitoring (ABPM) revealed 
a high average blood pressure. Therefore, we excluded white 
coat hypertension. Central pressure analysis showed a high 
central pressure. Measurement of blood pressure in all 4 limbs 
showed similar values.
We evaluated the patient for possible pheochromocytoma. 
Her plasma metanephrine and normetanephrine levels were 
within the reference range. We performed 24-hour urinary 
collection for metanephrine repetitively, but the values were 
within the reference range. We performed a positron emission 
tomography-computed tomography to explore a possible mass 
because she had fever of unknown origin. A positron emission 
tomography-computed tomography, which was performed 5 
months previously, showed no abnormal metaiodobenzylgua-
nidine (MIBG) uptake.
Magnetic resonance imaging (MRI) of the renovascula-
ture, to exclude renovascular hypertension, showed normal 
renal arteries. Evaluation of hyperaldosteronism or Cushing 
syndrome showed normal renin and aldosterone levels with 
no increase in the aldosterone:renin ratio. An overnight dexa-
methasone suppression test revealed normal response, and the 
24-hour urinary cortisol level was within the reference range. 
An MRI of the brain was performed when she complained of 
blurred vision and headache. There was no focal lesion in the 
pituitary fossa or brain parenchyma; therefore, we excluded 
pituitary adenoma.
Next, we examined the plasma hormone levels. Plasma 
hormone levels were also within the reference range, and an 
insulin-induced hypoglycemia test was normal.
The patient had poor urinary output despite taking diuret-
ics. She drank >2 or 3 L of water daily, but her urinary out-
put was just <1 L. However, her plasma blood urea nitrogen 
and creatinine levels were normal. We suspected malignant 
nephropathy, but a diethylenetriaminepentaacetic acid reno-
gram showed normal glomerular filtration rate. We considered 
a urinary tract problem and, therefore, performed an urody-
namic study that showed acontractile detrusor. She was edu-
cated on how to use intermittent catheterization, but her blood 
pressure was not improved.
Because the patient was obese, we evaluated the possibil-
ity of obstructive sleep apnea. Her polysomnography result 
showed an apnea–hypopnea index of 0.5, which is normal. 
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The patient was taking >4 oral antihypertension drugs includ-
ing an angiotensin receptor blocker, β-blocker, calcium chan-
nel blocker, and diuretics (Table 1). However, her blood 
pressure remained uncontrolled. IV nicardipine and a calcium 
channel blocker improved her blood pressure somewhat. We 
tried to replace the IV-infused calcium channel blocker with 
oral medication, unsuccessfully.
Discussion: Managing the Hypertension
Professor Park: I am the attending physician for this patient. 
In summary, the patient was an obese woman in her 30s. She 
had diabetes mellitus, and she initially had a high blood pres-
sure that was absolutely unresponsive to all oral medications. 
Initially, because the echocardiogram, the ECG, and the fun-
duscopy results were benign, we initially suspected white coat 
hypertension. However, when we did an ambulatory blood 
pressure–monitoring test, we found that her blood pressure 
was extremely high. I do not think that it was a case of white 
coat effect. Perhaps the blood pressure elevation happened 
recently. This is just a cross-sectional slide to show the types 
of medications that we were using at this period (Table 1). We 
tried using different combinations. We used different types of 
β-blockers, angiotensin receptor blockers, and angiotensin-
converting enzyme inhibitors. Despite our efforts, she was not 
responsive. I was wondering if any of you experts have any 
suggestion. What you would do with this particular patient at 
this moment?
Professor Touyz: Perhaps while the audience is thinking 
of some questions, I would just like to ask you, in terms of 
the patient profile, I think there were 2 significant factors: she 
had preeclampsia and she was obese. Perhaps you could tell 
us how you took this into account in terms of this complex, 
severely hypertensive patient?
Professor Park: Preeclampsia itself is a risk factor for 
future hypertension. However, she had preeclampsia 3 years 
before she was admitted, and after her second delivery, she did 
not have hypertension.
Professor Touyz: Did she remain obese?
Professor Park: She was obese. I think she gained close to 
20 kg during her pregnancy.
Professor Touyz: Has she remained obese thereafter?
Professor Park: Yes.
Professor Touyz: One more question I would like to ask 
you in terms of what you have shared with us, I do not recall 
seeing heart rate variability and characterization of her heart 
rate. Could you comment on the heart rate?
Professor Park: The heart rate was relatively high. It was 
between 80 and 100 bpm despite us using full-dose β-blockers.
Professor Dominiczak: I would like to go a step back. To 
exclude secondary hypertension, you did an extremely detailed 
set of investigations, and I understand this is an extreme case 
of high blood pressure (a difficult case). However, I am not 
sure I would have performed an MIBG scan considering the 
normal levels of catecholamines and metabolites. The number 
of tests and the detailed testing is more than I think we would 
have done in an European patient. Can you explain this dif-
ference of approach? My second question is, are you 100% 
certain that she takes all these complex cocktails of drugs? 
Have you checked, both by direct observation and measuring 
the levels, whether the drugs are truly consumed every day (in 
the appropriate manner)?
Professor Park: That is an excellent point. This positron 
emission tomography–computed tomography was performed 
before she was referred to me because she had a fever of 
unknown origin. In a previous positron emission tomography 
scan that was performed several months ago, there was no 
abnormal uptake to suggest pheochromocytoma or extra-adre-
nal paragangliomas. Because of the patient’s unresponsiveness 
to the medications, we referred her to Seoul National University 
Hospital for a second opinion. This particular MIBG scan was 
performed at Seoul National University Hospital. In our hospi-
tal, her urine catecholamines were evaluated, and her MRI renal 
angiography was performed to rule out renal artery stenosis.
Professor Touyz: Just getting back to the medication. We 
saw she was on this complex cocktail of many different anti-
hypertensive medications. Yet, she continued to have a relative 
Table 1. Antihypertensive Medications Before Procedures
Initial Medications
Combination of Medications Used Before the 
First Renal Denervation
Telmisartan 80 mg QD Captopril 50 mg TID
Cilnidipine 5 mg QD Amlodipine 10 mg QD
Carvedilol 12.5 mg QD Diltiazem 90 mg QD
Furosemide 20 mg BID Bisoprolol 2.5 mg BID
 Doxazosin 4 mg BID
 Torasemide 10 mg QD
 Chlorthalidone 25 mg BID
 Spironolactone 50 mg BID
 Isosorbide dinitrate 40 mg BID
 Cadralazine 10 mg QD
 Minoxidil 5 mg BID
Figure 1. Algorithm for diagnosis of resistance hypertension. 
Adapted from Calhoun et al1 with permission of the publisher. 
Copyright © 2008, the American Heart Association. Authorization 
for this adaptation has been obtained both from the owner of the 
copyright in the original work and from the owner of copyright in 
the translation or adaptation.
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tachycardia even though she was on all these β-blockers and 
other blockers. Did you at first suspect whether she was com-
pliant, because that is always a good indication, and second, did 
you consider an association with sympathetic hyperactivity?
Professor Park: She was admitted to the ward for a long 
period for follow-up, and because we suspected poor compli-
ance, our attending physicians, our house staff, and our nurses 
made sure that she took the medications. That is how we ruled 
out noncompliance.
Dr Jennings: I think we must accept that sometimes we 
encounter these patients that we cannot explain, with high 
blood pressure and no evidence of target-organ damage. This 
patient has been worked up as well as anybody you could ever 
see. I think most of my questions have been asked. I have a 
question regarding her fluid balance. I think you showed us 
records over 9 days when she was theoretically accumulating 
a liter a day. Are you suggesting that all the urine was in her 
bladder? Was it collected when she was catheterized or was 
she somehow doing something with her urine collection?
Professor Park: She seemed to have primary polydipsia, 
and she would drink 3 or 4 L of water per day. Even when she 
was admitted, while we told her not to do that, she would drink 
water continuously. The fluid balance would be incredible. It 
would be around 4 L of intake and only 500 mL of output. It 
was very, very bizarre. In 2 or 3 weeks, she would gain 5 kg of 
weight just by drinking a lot of fluid, and we could not explain 
why. She did not have an adequate urine output, so we evalu-
ated for neurogenic bladder with vesicoureteral reflux and 
obstructed uropathy. However, although the results revealed 
that she had a neurogenic bladder, the renogram showed nor-
mal kidney function, and she did not have any vesicoureteral 
reflux. I cannot explain why she had such a low urine output. 
However, later, when a cystostomy was performed at Seoul 
National University Hospital, the urine output was normal-
ized. It may have had to do with the neurogenic bladder.
Professor Cho: I am from Catholic University, South 
Korea, and my question is also related to her heart rate. Are 
you sure that you use a blood pressure cuff with appropri-
ate thickness when you measure all patients’ blood pressure? 
Did you ever try to measure her blood pressure invasively? 
Because her left ventricle mass is normal. Under 70… I 
remember, 70 g per blood surface area, so it is too normal for 
her blood pressure. Also, was there history of or current use of 
ginseng medication or herbal medication?
Professor Park: Again, she was followed-up for a long 
period. While she was admitted to the hospital, we made sure 
she did not take any ginseng or any other herbal medications. 
The answer to the question whether we evaluated for inva-
sive blood pressure is no. It would have been too invasive for 
this kind of patient. But to answer your question, while we 
were doing renal denervation, she received IV anesthesia, and 
her blood pressure decreased to 130 mm Hg. Based on this, 
I think some components of extreme anxiety and increased 
sympathetic nervous system activity may have contributed to 
her extreme high blood pressure.
Professor Cho: How was her urinary secretion of sodium 
(because she drinks too much water)?
Professor Park: We did not evaluate 24-hour sodium 
excretion, but I think you make a great point.
Progress
During this time, the Renal Denervation SYMPLICITY 
Korean Registry was started. We were fortunate enough to 
enroll this patient into the Registry trial and initially, in April 
of 2012, we performed renal denervation. Eight ablations were 
made to the right renal artery and 6 to the left. Initially, we 
thought there was some response, but as you can see, after con-
tinued follow-up, there was absolutely no response to the renal 
denervation during the 3 more months of follow-up (Figure 2). 
After this, I had no options left. I did not know what to do with 
this patient. I suggested that maybe she could get evaluated at 
another leading hospital in Korea, Seoul National University. I 
sent the patient to Lee, the next presenter. After renal denerva-
tion, what other treatment options are there? Are there other 
treatment options that you are aware of that we could select 
now? I think some input from the audience would be helpful.
Treatment Options: Post–Renal Denervation
Professor Touyz: Could you tell us at this point, when you felt 
you had no other options, what medications she was taking?
Professor Park: She was still taking all the medications 
that I previously mentioned.
Professor Touyz: Regarding the ABPM and the heart rate, 
did you see any nocturnal or 24-hour or circadian rhythm 
changes in this patient on repeated testing?
Professor Park: This is the ambulatory blood pressure data 
(Figure 3). You can see the nocturnal blood pressure.
Professor Touyz: The figure shows evidence of reverse 
dipping. Of course, as we all know, this is not a good marker 
of cardiovascular risk and worse cardiovascular outcomes. 
Interestingly, even though there was no evidence of target-
organ damage at the age of 31, as determined clinically and 
by specialized investigations, there is a significant finding in 
terms of her ABPM with reverse dipping phenomenon.
Professor Dominiczak: This is a case one encounters once 
in a lifetime, that is almost unresolvable, and it is puzzling 
because it is similar to a case that was presented ≈2 weeks ago, 
in Orlando, at the meeting of the American Heart Association 
Council for Hypertension. This was a case presented by a 
physician and neurosurgeon, because the patient, after having 
been through all these procedures including renal denervation, 
etc, has asked to have a neurosurgical procedure, a deep brain 
stimulation that has helped. This was n=1. Only one such case 
was done in this Center in Bristol in United Kingdom.2 I think 
there is an uncanny similarity between these 2 cases, and I 
think there must be some neurogenic mechanism that is driv-
ing this hypertension. Have you further evaluated sympathetic 
nerve activity? Have you thought about examining the kidneys 
again? Maybe, there is still hope in performing another proce-
dure because I think the tablets are not working.
Professor Park: In Korea, vasosympathetic nervous activ-
ity measurement is not available.
Dr Hering: It is a difficult case to find the best approach, 
and I am still wondering whether there may be an association 
with the anxiety or stress level in this patient. Some patients 
may not tolerate ABPM, and they may be a little bit stressed. 
One approach is the automated unobserved blood pressure 
measurements when we leave the room and leave the patient 
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alone. We may get similar readings to those of ABPM. With 
patients who are obese, they often do not tolerate the arm 
cuffs, which also may trigger the blood pressure.
Considering that the patient has polydipsia, we cannot 
exclude that she may also get up during the night to drink, 
which may also have an effect on the night-time blood pres-
sure. It is a complicated case, and in this scenario, we look for 
the procedure. Maybe 3 months is short term for the effect of 
renal denervation, and indeed, the sympathetic nervous system 
activity may help us to identify whether the neurogenic com-
ponent triggered this scenario. However, this is not available.
There is deep brain stimulation that was reported in one case 
report, and it is one of the options. However, in another confer-
ence presentation, it was reported that there is also a rebound 
effect after 18 months; even after deep brain stimulation, there 
is increased blood pressure again after the base (interventional) 
approaches for the treatment. We still do not know whether it 
is related to central anastomoses, deep brain stimulation, renal 
denervation, or even carotid body removal because there is 
no such data. In some patients, it is really the anxiety level. 
Providing the patient with guidance on how to manage stress 
may help to reduce the blood pressure in some cases.
Professor Park: Yes. I think that is a great point. I have a 
lot of so-called refractory hypertension patients who respond 
to antianxiety medications such as alprazolam. However, in 
this case, I tried all kinds of antianxiety medications. I asked 
for a psychiatric consultation, and the psychiatric consultation 
note was that she did not have any psychiatric signs of anxiety 
disorder. She also did not have any response to alprazolam. 
The only treatment that was successful was IV antihyperten-
sive drugs. IV nicardipine reduced her blood pressure but not 
oral medications.
Professor Touyz: That brings me to a important point. As 
clinicians, we all struggle when see patients such as this who 
come with 8, 9, or 12 drugs and the blood pressure remains at 
180 or 200 mm Hg. Did you at any point consider stopping all 
her medication? Titrating the medication down. I mean, not 
stopping everything at once, but slowly removing the medica-
tion to see if that had an impact at all? Because sometimes, 
this is an approach to help even from a diagnostic point of 
Figure 2. Blood pressure during 3 mo 
after renal denervation.
Figure 3. Ambulatory blood pressure (BP) before renal denervation.
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view to determine what may be working from a mechanis-
tic point of view. At any point, did you down-titrate because 
whatever you were adding was having absolutely no benefit?
Professor Park: I did not do any down titration. After sev-
eral weeks or several months, I would switch medications 
from the same class, different drugs for example. Using biso-
prolol, if there was no response, I would switch to nebivolol 
or carvedilol. However, I did not down-titrate the medications.
Professor Touyz: I think you bring up something 
extremely interesting, and it is the fact that she responded to 
IV β-blockers but not to oral β-blockers. Despite all the moni-
toring, this would make you think, is she taking her oral medi-
cation? I think we should still be a little bit cautious in terms 
of how sincere she is despite the monitoring because as you 
know, patients can be clever in their maneuvers.
Dr Jennings: Just following up on Hering’s comments on 
the sympathetic activity, we have learned a lot about renal 
denervation since SYMPLICITY HTN-3 and particularly about 
the technique and making sure that the lesions are distal in the 
renal circulation and that multiple lesions are made. I just won-
dered when you went back over it, were you satisfied you had 
used a satisfactory technique? It does emphasize how badly we 
need simple tests of the effectiveness of these interventions.
Professor Park: I think that is a wonderful comment. At 
the start, she was the second patient from the Registry, so our 
interventional cardiologist, B.-K. Kim, was relatively conser-
vative in his approach to the intervention. At the time of the 
procedure, the association between the number of ablations 
and the degree of blood pressure reduction had not been estab-
lished, and there was a real concern about the safety of too 
much ablation of the renal arteries. He did not know whether 
too much ablation could be harmful to the patient. Later, 
the number of ablations was not satisfactory to him. With 
increased cases, he would do more ablations for each artery. I 
will show you the next procedure that was done in this patient 
that shows a more aggressive approach by Kim.
Additional Procedures
Before I sent the patient to Seoul National to get a sec-
ond opinion, I did a lot of searching. What about nitrates 
plus phosphodiesterase type 5 inhibitors? Will that work? 
Unfortunately, the answer was no. There was a small study 
published in Hypertension, which shows that combining 
nitrates with Viagra can have a significant reduction in blood 
pressure.3 We tried it, and initially it worked. There was a huge 
drop in blood pressure, but it became refractory after several 
days. We waited for a response, but there was no response, so 
we discarded this as noneffective.
The patient agreed to go to Seoul National for a second 
opinion. The evaluation there was also all negative as expected, 
but because of her neurogenic bladder, they performed a cystos-
tomy. Also, they were doing a therapeutic drug-monitoring study 
for fimasartan and amlodipine at this time, after the cystostomy, 
and she was enrolled into the study. She took 10 mg of amlodip-
ine. A interesting finding was that compared with what would 
be expected for normal patients, she only had about one third of 
the drug concentration for amlodipine and fimasartan (Table 2).
We suspected that because the blood pressure is respon-
sive to IV drugs but not to oral medication, she has some 
sort of an absorption problem of the oral medications. There 
are some references to show this in patients with history 
of inflammatory bowel disease, which she had but was in 
remission. There are cases of high multidrug resistance in 
patients who fail medical therapy.4,5 There are some cases 
where some polymorphisms are associated with decreased 
response to amlodipine according to genotype.6 Maybe this is 
such a case, but we could not confirm this. After that, Seoul 
National University said, “We give up.” They sent her back to 
me. However, before that, Lee at Seoul National University 
and I had a deep discussion about this patient and, “Maybe,” 
he said, “why don’t you consider a sympathectomy for this 
patient?” Although sympathectomy has not been performed 
in the past 60 years, it has shown to be effective for reducing 
blood pressure. She wanted to get another opinion and came 
back to me to get further treatment.
After many discussions, we decided to repeat renal dener-
vation in this patient. We contacted Medtronic to get their per-
mission to do another procedure for this patient. Studies have 
shown that with increasing number of ablations, there is a sig-
nificantly better reduction in blood pressure. We did a repeat 
denervation.7 By this time, the interventional cardiologist had 
more experience doing this procedure so he performed a sig-
nificantly increased number of ablations of both arteries. After 
the second denervation, there was a slight decrease in the 
blood pressure. This got our hopes up, but the blood pressure 
started to go back up again. After 3 weeks, the blood pressure 
was at a range of 180/130 to 180/140 mm Hg, and the patient 
was still taking a high number of medications. What other 
options are left for this patient at this time? Should we at this 
point wait for several more months to see a delayed response 
or other nonpharmacological treatment? Other options such as 
baroreceptor modulation, arteriovenous fistula, or deep brain 
stimulation were not available at that time and are still not 
available in Korea. Any other suggestions at this time?
Discussion: Additional Therapies?
Dr Hering: Some of the patients, in rare cases, have neuro-
vascular compression on the left side that may be seen on an 
MRI scan. Years ago, a German group published data on many 
patients.8–10 Some patients with elevated blood pressure have 
neurovascular compression. When the pressure on the nerve 
is released, particularly VIII and IX on the left side, there is 
a related reduction in blood pressure and muscle sympathetic 
nerve activity. It is not a direct treatment for hypertension but 
the cause that leads to consistently elevated blood pressure.
We sometimes identify the nerve, particularly from VII-X; 
there could be compression usually on the left side. We tried 
showing why the risk reduction in blood pressure and mass 
sympathetic nerve activity in patients with resistant hyperten-
sion who have neurovascular compression and a release of the 
pressure could show a rebound effect ≤8 months later.10 This 
is a different procedure to the deep brain stimulation, but it 
was the case in some patients, including children. Even if you 
give a high dose of angiotensin receptor antagonist like cande-
sartan (Atacand) or telmisartan, some patients may have neu-
rovascular compression. A simple MRI (looking at the nerve, 
particularly on the left side) may identify that this is the cause 
of the consistently elevated blood pressure.
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History of Sympathectomy
I am going to briefly show you the history of sympathectomy 
because this was the last option to consider. It was a treatment 
for severe hypertension during the 1930s and 1950s. However, 
after the development of powerful antihypertensive drugs, it 
was discarded into the history books. Although it was effec-
tive, it had a significant morbidity and mortality rate (serious 
complications, <2%; transient back pain, 96%; transient diar-
rhea, 44%; and lower extremity paralysis with loss of bladder 
and bowel function, <0.15%).11
The celiac plexus is a important plexus of sympathetic 
nerves. It consists of the greatest splanchnic nerve, the lesser 
splanchnic nerve, and the least splanchnic nerve. It supplies 
most of the organs of the upper abdomen. This is a important 
article published in the JCI in 1996 when they did sampling 
from 7 subjects undergoing abdominal surgery.12 They sam-
pled blood from the portal vein, the systemic arteries, and the 
hepatic veins. What they found was that out of the total norepi-
nephrine spillover, 42% of the norepinephrine spillovers are 
contributed by the mesenteric and the hepatic spillover. This 
shows that the celiac plexus is associated with a significant por-
tion of the total neurohormonal stimulation in normal subjects.
This was another study that was published in Hypertension 
where they induced angiotensin II and salt-induced increase in 
sympathetic nervous system activity and hypertension.13 This 
study showed that in rats, celiac ganglionectomy, but not renal 
denervation, was associated with significant control of blood 
pressure. When they analyzed the norepinephrine level in each 
major organ, the renal denervation did not cause changes in 
the norepinephrine content, but celiac ganglionectomy had 
a significant reduction in the norepinephrine content of the 
major organs. You can see that blocking the celiac nervous 
system is more powerful than renal denervation in reducing 
sympathetic outflow. Currently, the celiac plexus block indi-
cation is intractable abdominal pain. This is a major indica-
tion, but historically, this was performed for other indications 
such as ischemic ulceration, hyperhidrosis, and hypertension. 
If it is performed with an expert hand, the rate of serious 
complication is <1%. The major complication from this pro-
cedure is hypotension, which has been reported to be ≤50% 
and transient diarrhea. It has been performed since 1914 as a 
procedure by anesthesiologists.
Case Resolution
We contacted the Anesthesiology Department, and they ini-
tially performed a test block of the right celiac plexus. She 
showed a significant drop in her blood pressure. Because 
the test celiac plexus block seemed to work, a second plexus 
block at the right celiac plexus with dehydrated alcohol was 
performed. This was also associated with a significant drop, 
close to 50 mm Hg, in her blood pressure. After that, we did a 
third block of the left celiac plexus with lidocaine and ropiva-
caine with a similar level of blood pressure drop.
After I reported this case in a Korean meeting, there was 
another case reported by the Catholic University of Korea, 
which involved an 18-year-old male patient who was abso-
lutely refractory to all kinds of oral medications. The renal 
denervation failed, and they performed a celiac plexus block 
with botulunim toxin after which the blood pressure was con-
trolled. The case was reported in the journal Toxins.14
In our case, after the second renal denervation and the 
plexus block, the blood pressure started to fall, approximately 
around April. The patient had symptoms of hypotension, so 
all medications were removed. Currently, her progress is very, 
very good. Her nocturnal blood pressure was elevated, but her 
awake mean blood pressure with ABPM dropped to 134/83 
mm Hg without any medications. Her progress until now is 
recurrent hospitalization because of complications from the 
cystostomy, but she is currently normotensive without any 
antihypertensive medications.
Final Comments and Questions
Professor Touyz: I just want to go back one more time. When 
you repeated the ABPM, did she still exhibit the reverse dip-
ping phenomenon?
Professor Park: She still did, yes.
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Professor Touyz: Even though her blood pressure had 
come down by 50 mm Hg, did she still have the higher night-
time blood pressure?
Professor Park: Yes, she did.
Professor Dominiczak: I think you succeeded which is 
great. We do not completely understand why. It must be a neu-
rogenic mechanism. When things went really wrong, and she 
was on all these drugs, and you were doing first and second 
renal denervation and things did not work, how did she feel? 
Was she a sick lady? Or was she somebody who had high 
blood pressure but otherwise was fine when you went to see 
her in the morning?
Professor Park: It was the second case. The only thing she 
had was elevated blood pressure, and when the blood pressure 
was elevated >180 to 200 mm Hg, she had some headaches, 
nothing more.
Professor Dominiczak: Great success for you.
Professor Park: Yes.
Professor Touyz: Thank you. Indeed, the patient is lucky. 
We still do not understand the mechanisms. Maybe essential 
hypertension after all.
Summary
We present a case of refractory hypertension controlled 
through renal denervation and celiac plexus block. The mech-
anism for hypertension remains unclear, but the patient is 
now normotensive without oral medication after repeat renal 
denervation and celiac plexus block.
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